JP2013241476A5 - - Google Patents

Download PDF

Info

Publication number
JP2013241476A5
JP2013241476A5 JP2013188248A JP2013188248A JP2013241476A5 JP 2013241476 A5 JP2013241476 A5 JP 2013241476A5 JP 2013188248 A JP2013188248 A JP 2013188248A JP 2013188248 A JP2013188248 A JP 2013188248A JP 2013241476 A5 JP2013241476 A5 JP 2013241476A5
Authority
JP
Japan
Prior art keywords
topiramate
sodium
solid preparation
crystals
carmellose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013188248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013241476A (ja
JP6125957B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013188248A priority Critical patent/JP6125957B2/ja
Priority claimed from JP2013188248A external-priority patent/JP6125957B2/ja
Publication of JP2013241476A publication Critical patent/JP2013241476A/ja
Publication of JP2013241476A5 publication Critical patent/JP2013241476A5/ja
Application granted granted Critical
Publication of JP6125957B2 publication Critical patent/JP6125957B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013188248A 2007-04-12 2013-09-11 トピラマート含有固形製剤 Active JP6125957B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013188248A JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007104853 2007-04-12
JP2007104853 2007-04-12
JP2013188248A JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008103209A Division JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016207609A Division JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Publications (3)

Publication Number Publication Date
JP2013241476A JP2013241476A (ja) 2013-12-05
JP2013241476A5 true JP2013241476A5 (cg-RX-API-DMAC7.html) 2014-02-13
JP6125957B2 JP6125957B2 (ja) 2017-05-10

Family

ID=40141447

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008103209A Active JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤
JP2013188248A Active JP6125957B2 (ja) 2007-04-12 2013-09-11 トピラマート含有固形製剤
JP2016207609A Pending JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008103209A Active JP5424571B2 (ja) 2007-04-12 2008-04-11 トピラマート含有固形製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016207609A Pending JP2017014289A (ja) 2007-04-12 2016-10-24 トピラマート含有固形製剤

Country Status (1)

Country Link
JP (3) JP5424571B2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
NZ703128A (en) * 2010-05-11 2016-04-29 Janssen Pharmaceutica Nv Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
WO2012140120A1 (en) 2011-04-13 2012-10-18 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
IN2013MU02470A (cg-RX-API-DMAC7.html) * 2013-07-25 2015-06-26 Cadila Healthcare Ltd
CN108379588B (zh) * 2018-03-05 2024-07-02 合肥合源药业有限公司 托吡酯组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
EP1157682A1 (en) * 2000-05-25 2001-11-28 Cilag AG Blister package for topiramate tablets
DE10153078A1 (de) * 2001-10-30 2003-05-22 Degussa Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
US7390505B2 (en) * 2003-01-31 2008-06-24 Elan Pharma International, Ltd. Nanoparticulate topiramate formulations
WO2005065648A2 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Novel drug compositions and dosage forms of topiramate
EP2394643B1 (en) * 2006-11-17 2015-09-02 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
EP2363113B1 (en) * 2006-12-04 2017-08-02 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate

Similar Documents

Publication Publication Date Title
JP2014533655A5 (cg-RX-API-DMAC7.html)
MX2015016070A (es) Composiciones antitranspirantes.
JP2009517023A5 (cg-RX-API-DMAC7.html)
WO2014070928A3 (en) Sodium hypochlorite composition
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
PH12015502368B1 (en) Antiperspirant compositions
EA201300053A1 (ru) Фосфатсвязывающий препарат для удобного приема
CA2647492A1 (en) Stabilization of milk of lime suspensions
JO3229B1 (ar) العمل على استقرار الهرمون المنبه للجريب
MY190283A (en) Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
JP2016523803A5 (cg-RX-API-DMAC7.html)
RU2012110758A (ru) Способ получения сахарсодержащего продукта
PH12014501981A1 (en) Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
RU2014143976A (ru) Таблетки, содержащие 5-гидрокси-1н-имидазол-4-карбоксамид
EA201291022A1 (ru) Твердая фармацевтическая композиция для нейтрализации желудочной кислоты
EA201591090A1 (ru) Способ изготовления минеральной соли и продукта на основе минеральной соли
HRP20211524T1 (hr) Sol derivata cefalosporina, kristalni kruti oblik istog i postupak za njegovu proizvodnju
RU2013151914A (ru) Способ получения глинозема
JP2016074851A5 (cg-RX-API-DMAC7.html)
WO2014006635A3 (en) Solid oral compositions of silodosin
RU2017140923A (ru) Стабилизированная фармацевтическая композиция
JP2013047300A5 (cg-RX-API-DMAC7.html)
RU2010150469A (ru) Способ получения ангидрата и гидратов динатриевой соли кремниевой кислоты (метасиликата натрия) безводных, пятиводных, шестиводных, девятиводных
WO2014147636A8 (en) 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists
JP2013253064A5 (cg-RX-API-DMAC7.html)